Gemphire Therapeutics Inc. Contracts & Agreements
122 Contracts & Agreements
- Business Finance (41 contracts)
- Business Operations (7)
- Human Resources (35)
- Intellectual Property (3)
- Mergers & Acquisitions (2)
- Real Estate (6)
- Uncategorized (28)
- Employment Agreement entered into on March 1, 2024 by and between NeuroBo Pharmaceuticals, Inc. and Marshall H. Woodworth (Filed With SEC on March 4, 2024)
- Lease Agreement, dated as of August 23, 2023, by and between Alewife Properties LLC and NeuroBo Pharmaceuticals, Inc (Filed With SEC on November 13, 2023)
- Employment Agreement entered into on August 11, 2023 by and between NeuroBo Pharmaceuticals, Inc. and Hyung Heon Kim (Filed With SEC on August 14, 2023)
- Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on June 29, 2023)
- Amendment to Dong-A Series A Warrant (Filed With SEC on April 14, 2023)
- Amendment to Dong-A Series B Warrant (Filed With SEC on April 14, 2023)
- Description of Securities (Filed With SEC on March 30, 2023)
- Amendment to Membership Agreement, dated December 14, 2022 by and between WeWork and the Registrant (Filed With SEC on March 30, 2023)
- Separation and Release Agreement entered into on January 16, 2023 by and between NeuroBo Pharmaceuticals, Inc. and Gil Price (Filed With SEC on January 18, 2023)
- NeuroBo Pharmaceuticals, Inc. 2022 Equity Incentive Plan, effective as of December 22, 2022 (Filed With SEC on December 22, 2022)
- NeuroBo Pharmaceuticals, Inc. 2022 Equity Incentive Plan Forms of Option Grant Agreements (Filed With SEC on December 22, 2022)
- Amendment to Membership Agreement, dated August 30, 2022, by and between WeWork and the Registrant (Filed With SEC on November 14, 2022)
- Underwriting Agreement dated as of November 4, 2022, by and between NeuroBo Pharmaceuticals, Inc. and Ladenburg Thalmann & Co. Inc (Filed With SEC on November 8, 2022)
- Form of Series A Warrant to purchase shares of common stock (Filed With SEC on November 8, 2022)
- Form of Series B Warrant to purchase shares of common stock (Filed With SEC on November 8, 2022)
- Warrant Agency Agreement (Filed With SEC on November 8, 2022)
- Form of Dong-A Series A Warrant to purchase shares of common stock (Filed With SEC on November 8, 2022)
- Form of Dong-A Series B Warrant to purchase shares of common stock (Filed With SEC on November 8, 2022)
- Form of Underwriting Agreement between the Registrant and Ladenburg Thalmann & Co. Inc (Filed With SEC on November 3, 2022)
- Form of Series A Warrant offered hereby (Filed With SEC on November 3, 2022)
- Form of Series B Warrant offered hereby (Filed With SEC on November 3, 2022)
- Form of Leak-Out Agreement (Filed With SEC on November 3, 2022)
- Form of Voting Agreement to be executed by Dong-A ST Co. Ltd and Roy Lester Freeman (Filed With SEC on November 3, 2022)
- Form of Lock-Up Agreement to be executed by Dong-A ST Co. Ltd and Roy Lester Freeman (Filed With SEC on November 3, 2022)
- Form of Voting Agreement to be executed by entities affiliated with E&Investment, Inc (Filed With SEC on November 3, 2022)
- Form of Lock-Up Agreement to be executed by entities affiliated with E&Investment, Inc (Filed With SEC on November 3, 2022)
- Form of Underwriting Agreement between the Registrant and Ladenburg Thalmann & Co. Inc (Filed With SEC on October 24, 2022)
- Form of Warrant Agency Agreement between the Registrant and American Stock Transfer & Trust Company (Filed With SEC on October 24, 2022)
- Form of Warrant offered hereby (Filed With SEC on October 24, 2022)
- License Agreement, between by and between Dong-A ST Co., Ltd. and the Company, dated September 14, 2022 (Filed With SEC on September 14, 2022)
- Shared Services Agreement, between by and between Dong-A ST Co., Ltd. and the Company, dated September 14, 2022 (Filed With SEC on September 14, 2022)
- Securities Purchase Agreement, by and between Dong-A ST Co., Ltd. and the Company, dated September 14, 2022 (Filed With SEC on September 14, 2022)
- Registration Rights Agreement, by and among Dong-A ST Co., Ltd., The E&Healthcare Investment Fund II, The E&Healthcare Investment Fund No. 6, The E&Healthcare Investment Fund No.... (Filed With SEC on September 14, 2022)
- Investor Rights Agreement, by and between Dong-A ST Co. Ltd. and the Company, dated September 14, 2022 (Filed With SEC on September 14, 2022)
- Amendment to Membership Agreement, dated April 19, 2022, by and between WeWork and the Registrant (Filed With SEC on August 12, 2022)
- Amendment to Membership Agreement, dated December 23, 2021, by and between WeWork and the Registrant (Filed With SEC on March 31, 2022)
- Amendment to Membership Agreement, dated February 9, 2022, by and between WeWork and the Registrant (Filed With SEC on March 31, 2022)
- Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on January 28, 2022)
- NeuroBo Pharmaceuticals, Inc. 2021 Inducement Plan (Filed With SEC on November 4, 2021)
- Form of Stock Option Grant Notice, Option Agreement and Notice of Exercise under the NeuroBo Pharmaceuticals, Inc. 2021 Inducement Plan (Filed With SEC on November 4, 2021)
- Separation Agreement entered into on November 3, 2021 by and between NeuroBo Pharmaceuticals, Inc. and Richard Kang (Filed With SEC on November 4, 2021)
- Employment Agreement entered into on November 3, 2021 by and between NeuroBo Pharmaceuticals, Inc. and Gil Price (Filed With SEC on November 4, 2021)
- Form of Warrant to purchase shares of common stock (Filed With SEC on October 4, 2021)
- Form of Securities Purchase Agreement, dated as of October 1, 2021, by and among NeuroBo Pharmaceuticals, Inc. and the purchasers identified on the signature pagers thereto (Filed With SEC on October 4, 2021)
- RELEASE AGREEMENT (Filed With SEC on August 16, 2021)
- Membership Agreement by and between WeWork and NeuroBo Pharmaceuticals, Inc., dated May 14, 2021 (Filed With SEC on May 17, 2021)
- Description of Securities (Filed With SEC on April 15, 2021)
- Employment Agreement, dated as of December 31, 2020, by and between the Registrant and Akash Bakshi (Filed With SEC on April 15, 2021)
- First Amendment to Contingent Value Rights Agreement, dated as of December 30, 2019, by and among NeuroBo, the Holders Representative, and the Rights Agent, dated as of March 23,... (Filed With SEC on March 24, 2021)
- Form of Warrant (Filed With SEC on January 21, 2021)
- Form of Securities Purchase Agreement (Filed With SEC on January 21, 2021)
- Form of Registration Rights Agreement (Filed With SEC on January 21, 2021)
- Agreement and Plan of Merger, dated December 31, 2020, by and among NeuroBo Pharmaceuticals, Inc., Shelby Merger Sub 1, Inc., Shelby Merger Sub 2, LLC, ANA Therapeutics, Inc., and... (Filed With SEC on January 6, 2021)
- Form of Support Agreement (Filed With SEC on January 6, 2021)
- Form of Lock-Up Agreement (Filed With SEC on January 6, 2021)
- Membership Agreement by and between WeWork and NeuroBo Pharmaceuticals, Inc., dated November 11, 2020 (Filed With SEC on November 13, 2020)
- Dong-A ST CO., LTD. Manufacturing and Supply Agreement (NB-02 formerly DA-9803) dated June 7, 2020 (Filed With SEC on August 11, 2020)
- Form of Placement Agents Warrant (Filed With SEC on April 15, 2020)
- Form of Securities Purchase Agreement (Filed With SEC on April 15, 2020)
- Description of Securities (Filed With SEC on March 30, 2020)
- Membership Agreement by and between WeWork and NeuroBo Pharmaceuticals, Inc., dated January 9, 2020 (Filed With SEC on March 30, 2020)
- Offer Letter, dated as of January 29, 2020, by and between Nicola Shannon and NeuroBo Pharmaceuticals, Inc (Filed With SEC on March 30, 2020)
- Form of Incentive Stock Option Agreement for 2019 Equity Incentive Plan (Filed With SEC on March 30, 2020)
- Form of Restricted Stock Agreement for 2019 Equity Incentive Plan (Filed With SEC on March 30, 2020)
- Form of Non-Qualified Stock Option Agreement for 2019 Equity Incentive Plan (Filed With SEC on March 30, 2020)
- Form of Stock Unit Agreement for 2019 Equity Incentive Plan (Filed With SEC on March 30, 2020)
- Employment Agreement, dated February 11, 2020, by and between NeuroBo Pharmaceuticals, Inc. and Richard Kang (Filed With SEC on February 13, 2020)
- Contingent Value Rights Agreement, dated as of December 30, 2019, by and among the Company, Grand Rapids Holders Representative, LLC, Computershare Inc. and Computershare Trust... (Filed With SEC on December 31, 2019)
- 2019 Equity Incentive Plan (Filed With SEC on December 31, 2019)
- Consulting Agreement by and between vZenium LLC, owned and managed entirely by Mark Versavel, and NeuroBo Pharmaceuticals, Inc., dated May 1, 2018 and extension of such agreement,... (Filed With SEC on December 31, 2019)
- Offer Letter, dated as of August 20, 2018, by and between Nicola Shannon and NeuroBo (Filed With SEC on December 31, 2019)
- Form of Indemnification Agreement between NeuroBo Pharmaceuticals, Inc. and each of its directors and executive officers (Filed With SEC on December 31, 2019)
- First Amendment to Agreement and Plan of Merger and Reorganization, dated as of October 29, 2019, by and among Gemphire, Merger Sub and NeuroBo (Filed With SEC on October 29, 2019)
- Second Amendment to Employment Agreement between Gemphire Therapeutics Inc. and Dr. Steven Gullans dated September 30, 2019 (Filed With SEC on October 3, 2019)
- Second Amendment to Employment Agreement between Gemphire Therapeutics Inc. and Dr. Charles L. Bisgaier dated September 30, 2019 (Filed With SEC on October 3, 2019)
- Second Amendment to Employment Agreement between Gemphire Therapeutics Inc. and Seth Reno dated September 30, 2019 (Filed With SEC on October 3, 2019)
- Lease Agreement by and between Invest Korea Plaza and NeuroBo Co., Ltd., dated February 21, 2018 (Filed With SEC on September 3, 2019)
- Lease Agreement by and between Business District and NeuroBo Pharmaceuticals, Inc., dated April 19, 2018, and Addendum Nos. 1, 2 and 3 entered into thereunder (Filed With SEC on September 3, 2019)
- Manufacturing and Supply Agreement between Dong-A ST Co., Lt. and NeuroBo Pharmaceuticals, Inc., dated September 28, 2018 (Filed With SEC on September 3, 2019)
- Consulting Agreement by and between Healthcare Capital LLC, owned and managed entirely by John L. Brooks III and NeuroBo Pharmaceuticals, Inc., dated February 1, 2018; Replacement... (Filed With SEC on September 3, 2019)
- Consulting Agreement by and between vZenium LLC, owned and managed entirely by Mark Versavel, and NeuroBo Pharmaceuticals, Inc., dated February 1, 2018; Replacement Consulting... (Filed With SEC on September 3, 2019)
- Independent Contractor Agreement by and between Therabo PLLC and NeuroBo Pharmaceuticals, Inc., dated March 1, 2019 (Filed With SEC on September 3, 2019)
- Lease Agreement by and between Gyeonggi Urban Innovation Corporation and NeuroBo Co., Ltd., dated May 2, 2019 (Filed With SEC on September 3, 2019)
- Fourth Amended and Restated Stockholders' Agreement, by and among the Initial Holders and the Investors on Schedule A thereto and NeuroBo Pharmaceuticals, Inc., dated May 30, 2019 (Filed With SEC on September 3, 2019)
- License Agreement by and between Dong-A ST Co., Ltd. and NeuroBo Pharmaceuticals, Inc., dated January 18, 2018, as amended on April 18, 2018 and July 24, 2019 (Filed With SEC on September 3, 2019)
- Acquisition Agreement by and between Dong-A ST Co., Ltd. and NeuroBo Pharmaceuticals, Inc., dated January 18, 2018, as amended on April 18, 2018 and July 24, 2019 (Filed With SEC on September 3, 2019)
- 2018 Stock Plan for NeuroBo Pharmaceuticals, Inc (Filed With SEC on September 3, 2019)
- Form of Stock Option Agreement for NeuroBo Pharmaceuticals, Inc. to the 2018 Stock Plan (Filed With SEC on September 3, 2019)
- Form of Notice of Grant of Restricted Stock Purchase Right for NeuroBo Pharmaceuticals, Inc. to the 2018 Stock Plan (Filed With SEC on September 3, 2019)
- Form of Notice of Grant of Stock Option for NeuroBo Pharmaceuticals, Inc. to the 2018 Stock Plan (Filed With SEC on September 3, 2019)
- Form of Notice of Grant of Restricted Stock Bonus for NeuroBo Pharmaceuticals, Inc. to the 2018 Stock Plan (Filed With SEC on September 3, 2019)
- First Amendment to Employment Agreement dated as of July 24, 2019 by and between Gemphire and Steve Gullans (Filed With SEC on August 13, 2019)
- Acknowledgement of Lease Commencement between North Laurel Project, LLC and Gemphire Therapeutics Inc. dated August 26, 2016 (Filed With SEC on August 9, 2019)
- Employment Agreement by and between the Registrant and Seth Reno (Filed With SEC on March 18, 2019)
- Separation and Release Agreement with Jeffrey S. Mathiesen dated as of September 21, 2018 (Filed With SEC on November 8, 2018)
- Separation and Release Agreement with Dr. Lee Golden dated as of September 21, 2018 (Filed With SEC on November 8, 2018)
- Amended and Restated License Agreement effective August 2, 2018 by and between Gemphire Therapeutics Inc. and Pfizer Inc (Filed With SEC on August 6, 2018)
- Warrant to Purchase Stock, dated July 31, 2018, by and between Gemphire Therapeutics Inc. and Silicon Valley Bank (Filed With SEC on August 6, 2018)
- First Amendment to Loan and Security Agreement, dated as of July 31, 2018, by and between Gemphire Therapeutics Inc. and Silicon Valley Bank (Filed With SEC on August 6, 2018)
- AMENDMENT TO THE GEMPHIRE THERAPEUTICS INC. AMENDED AND RESTATED 2015 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS: April 9, 2018 APPROVED BY THE STOCKHOLDERS: May 22,... (Filed With SEC on May 24, 2018)
- Employment Agreement (Filed With SEC on May 3, 2018)
- AMENDMENT No. 1 TO THE Gemphire Therapeutics Inc. INDUCEMENT PLAN (Filed With SEC on April 12, 2018)
- 3,142,858 Shares Gemphire Therapeutics Inc. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on February 12, 2018)
- Separation and Release Agreement between Gemphire Therapeutics Inc. and Mina Sooch dated May 30, 2017 (Filed With SEC on August 14, 2017)
- Offer Letter between Gemphire Therapeutics Inc. and Dr. Steve Gullans dated June 8, 2017 (Filed With SEC on August 14, 2017)
- LOAN AND SECURITY AGREEMENT (Filed With SEC on July 25, 2017)
- GEMPHIRE THERAPEUTICS INC. FORM OF WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on March 13, 2017)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on March 13, 2017)
- REGISTRATION RIGHTS AGREEMENT (Filed With SEC on March 13, 2017)
- GEMPHIRE THERAPEUTICS INC. INDUCEMENT PLAN APPROVED BY THE BOARD OF DIRECTORS ON: September 30, 2016 (Filed With SEC on October 3, 2016)
- GEMPHIRE THERAPEUTICS INC. INDUCEMENT PLAN OPTION GRANT NOTICE (Filed With SEC on October 3, 2016)
- [] Shares Gemphire Therapeutics Inc. UNDERWRITING AGREEMENT (Filed With SEC on April 18, 2016)
- GEMPHIRE THERAPEUTICS INC. INVESTOR RIGHTS AGREEMENT (Filed With SEC on April 18, 2016)
- INDEMNIFICATION AGREEMENT Effective Date: , 2016 (Filed With SEC on April 18, 2016)
- GEMPHIRE THERAPEUTICS INC. 2015 EQUITY INCENTIVE PLAN APPROVED BY THE BOARD OF DIRECTORS: April 28, 2015 APPROVED BY THE STOCKHOLDERS: April 28, 2015 (Filed With SEC on April 18, 2016)
- EMPLOYMENT AGREEMENT (Filed With SEC on April 18, 2016)
- EMPLOYMENT AGREEMENT (Filed With SEC on April 18, 2016)
- EMPLOYMENT AGREEMENT (Filed With SEC on April 18, 2016)
- EMPLOYMENT AGREEMENT (Filed With SEC on April 18, 2016)
- OFFICE SPACE SUBLEASE AGREEMENT (Filed With SEC on April 18, 2016)
- FORM OF NOTE PURCHASE AGREEMENT (Filed With SEC on April 18, 2016)
- GEMPHIRE THERAPEUTICS INC. FORM OF NOTE PURCHASE AGREEMENT JOINDER AGREEMENT (Filed With SEC on April 18, 2016)